The Effect of High Dose Simvastatine on Multiple Myeloma
The purpose of the study is to evaluate the effect of high doses of Simvastatine on bone metabolisme and biochemical markers of disease in Multiple Myeloma
Multiple Myeloma
DRUG: Simvastatine
Response estimated by internationally approved criteria after 8 weeks of intermittend treatment with simvastatine, 8 weeks after treatment start
Changes in markers of bone metabolisme after 8 weeks of intermittend treatment with simvastatine, 8 weeks after start of treatment|Toxicity according to CTC after 8 weeks of intermittend treatment with simvastatine, 8 weeks after start of treatment
The purpose of the study is to evaluate the effect of high doses of Simvastatine on bone metabolisme and biochemical markers of disease in Multiple Myeloma